Varghese N
Psychiatric University Hospital, University of Basel, Basel, Switzerland.
ArticleDMT
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants.
ArticleMDMA
Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.
ArticleMDMA
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.
ArticlePsilocybin
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
ArticleDMT
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.
ArticleLSD
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.
ArticlePsilocybin
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
ArticlePsilocybin
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.
ArticleLSD
Role of the 5-HT<sub>2A</sub> Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin.
ArticleLSD
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
ArticleLSD
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.
ArticleMDMA